The incidence of epidermal growth factor receptor (EGFR) mutations in the Caucasian population is approximately 10%, but is higher among never-smokers, patients with adenocarcinoma, females, and individuals from East Asia [12]. The gene discussed is EGFR; the disease is adenocarcinoma.